Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 2
2005 2
2006 3
2007 4
2008 3
2009 3
2010 4
2011 7
2012 6
2013 8
2014 5
2015 3
2016 4
2017 3
2018 5
2019 4
2020 4
2021 4
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

69 results
Results by year
Filters applied: . Clear all
Page 1
Impact of SARS-CoV-2 on neuropsychiatric disorders.
Robinson-Agramonte MA, Gonçalves CA, Noris-García E, Préndes Rivero N, Brigida AL, Schultz S, Siniscalco D, García García RJ. Robinson-Agramonte MA, et al. Among authors: siniscalco d. World J Psychiatry. 2021 Jul 19;11(7):347-354. doi: 10.5498/wjp.v11.i7.347. eCollection 2021 Jul 19. World J Psychiatry. 2021. PMID: 34327127 Free PMC article. Review.
Speech-Stimulating Substances in Autism Spectrum Disorders.
Castillo MA, Urdaneta KE, Semprún-Hernández N, Brigida AL, Antonucci N, Schultz S, Siniscalco D. Castillo MA, et al. Among authors: siniscalco d. Behav Sci (Basel). 2019 Jun 12;9(6):60. doi: 10.3390/bs9060060. Behav Sci (Basel). 2019. PMID: 31212856 Free PMC article. Review.
SARS-CoV-2 Infection and Risk Management in Multiple Sclerosis.
Diaz de la Fe A, Peláez Suárez AA, Fuentes Campos M, Cabrera Hernández MN, Goncalves CA, Schultz S, Siniscalco D, Robinson-Agramonte MA. Diaz de la Fe A, et al. Among authors: siniscalco d. Diseases. 2021 Apr 19;9(2):32. doi: 10.3390/diseases9020032. Diseases. 2021. PMID: 33921878 Free PMC article. Review.
Stem cell therapy in autism: recent insights.
Siniscalco D, Kannan S, Semprún-Hernández N, Eshraghi AA, Brigida AL, Antonucci N. Siniscalco D, et al. Stem Cells Cloning. 2018 Oct 23;11:55-67. doi: 10.2147/SCCAA.S155410. eCollection 2018. Stem Cells Cloning. 2018. PMID: 30425534 Free PMC article. Review.
Stem Cell-Derived Exosomes in Autism Spectrum Disorder.
Alessio N, Brigida AL, Peluso G, Antonucci N, Galderisi U, Siniscalco D. Alessio N, et al. Among authors: siniscalco d. Int J Environ Res Public Health. 2020 Feb 4;17(3):944. doi: 10.3390/ijerph17030944. Int J Environ Res Public Health. 2020. PMID: 32033002 Free PMC article. Review.
Interferon beta 1a (Rebif®) in relapsing remitting multiple sclerosis.
Sánchez RC, de la Fe AD, Suarez AP, Grass D, Vega TM, Canal AS, Siniscalco D, de Los Angeles Robinson Agramonte M. Sánchez RC, et al. Among authors: siniscalco d. Drug Dev Res. 2021 Aug;82(5):707-715. doi: 10.1002/ddr.21798. Epub 2021 Feb 15. Drug Dev Res. 2021. PMID: 33586209
Editorial: Antioxidants in Autism Spectrum Disorders.
Bonomini F, Siniscalco D, Schultz S, Carnovale C, Barthélémy C, Fazzi EM. Bonomini F, et al. Among authors: siniscalco d. Front Psychiatry. 2022 Apr 7;13:889865. doi: 10.3389/fpsyt.2022.889865. eCollection 2022. Front Psychiatry. 2022. PMID: 35463522 Free PMC article. No abstract available.
Immunomodulatory effects of stem cells: Therapeutic option for neurodegenerative disorders.
Caprnda M, Kubatka P, Gazdikova K, Gasparova I, Valentova V, Stollarova N, La Rocca G, Kobyliak N, Dragasek J, Mozos I, Prosecky R, Siniscalco D, Büsselberg D, Rodrigo L, Kruzliak P. Caprnda M, et al. Among authors: siniscalco d. Biomed Pharmacother. 2017 Jul;91:60-69. doi: 10.1016/j.biopha.2017.04.034. Epub 2017 May 23. Biomed Pharmacother. 2017. PMID: 28448871 Review.
69 results